|
|
Volumn 8, Issue 1, 2002, Pages 1-7
|
|
Peptides as drugs: Is there a market?
a
a
Senn Chemicals
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ALPHA INTERFERON;
ANGIOPEPTIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA INTERFERON;
BLOOD CLOTTING FACTOR;
BUSERELIN;
CYTOKINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
ENZYME;
ERYTHROPOIETIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
GONADORELIN AGONIST;
GONADOTROPIN;
GOSERELIN;
GROWTH FACTOR;
GROWTH HORMONE;
HIRUDIN;
INSULIN;
LEUPRORELIN;
LISINOPRIL;
MONOCLONAL ANTIBODY;
NAFARELIN;
OCTREOTIDE;
RECOMBINANT PROTEIN;
SOMATOSTATIN DERIVATIVE;
SYNTHETIC PEPTIDE;
TRIPTORELIN;
UNINDEXED DRUG;
BREAST CANCER;
CLINICAL STUDY;
DIAGNOSTIC VALUE;
DRUG INDICATION;
DRUG MARKETING;
DRUG USE;
ENDOCRINE TUMOR;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
PEPTIDE SYNTHESIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
UNITED STATES;
DISULFIDES;
HUMANS;
PEPTIDES;
RECOMBINANT PROTEINS;
|
|
EID: 0036158878
PISSN: 10752617
EISSN: None
Source Type: Journal
DOI: 10.1002/psc.366 Document Type: Review |
|
Times cited : (164)
|
|
References (0)
|
